Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK-positive cell growth.

ABSTRACT: We used bisulfite conversion and Illumina sequencing to analyse miR-150 DNA methylation pattern lost in cells treated with decitabine, a demethylating agent, Crizotinib, an inhibitor of of ALK activity or siALK Targeted bisulfite conversion and Illumina sequencing in two cell lines bearing the t(2;5)(p23;q35)

ORGANISM(S): Homo sapiens

SUBMITTER: Coralie Hoareau-Aveilla 

PROVIDER: E-GEOD-69836 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress